Nufarm
Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and Latin America. The last earnings update was 65 days ago. More info.
Add to Portfolio Compare Print
- Nufarm has significant price volatility in the past 3 months.
NUF Share Price and Events
7 Day Returns
1 Year Returns
NUF Shareholder Return
| 7 Day | 30 Day | 90 Day | 1 Year | 3 Year | 5 Year | |
|---|---|---|---|---|---|---|
| Nufarm (NUF) | -0.7% | -16.6% | -14% | -52.3% | -41.6% | 4% |
| AU Chemicals | 3% | 3.3% | 13.7% | 1.8% | 18.5% | 22.5% |
| AU Market | 3.5% | 3.6% | 5.5% | 5.6% | 20.1% | 9.4% |
1 Year Return vs Industry and Market
- NUF underperformed the Chemicals industry which returned 1.8% over the past year.
- NUF underperformed the Market in Australia which returned 5.6% over the past year.
NUF Value
Is Nufarm undervalued based on future cash flows and its price relative to the stock market?
Value is all about what a company is worth versus what price it is
available for. If you went into a grocery store and all the bananas were on sale
at half price, they could be considered
undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current
share
price of
Nufarm
to its discounted cash flow analysis.value.The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Below are the data sources, inputs and calculation used to determine the intrinsic value for Nufarm.
| Data Point | Source | Value |
|---|---|---|
| Valuation Model | 2 Stage Free Cash Flow to Equity | |
| Levered Free Cash Flow | Average of 12 Analyst Estimates (S&P Global) | See below |
| Discount Rate (Cost of Equity) | See below | 10.4% |
| Perpetual Growth Rate | 10-Year AU Government Bond Rate | 2.3% |
An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.
| Data Point | Calculation/ Source | Result |
|---|---|---|
| Risk-Free Rate | 10-Year AU Govt Bond Rate | 2.3% |
| Equity Risk Premium | S&P Global | 6% |
| Chemicals Unlevered Beta | Simply Wall St/ S&P Global | 0.87 |
| Re-levered Beta | = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.871 (1 + (1- 30%) (109.55%)) |
1.361 |
| Levered Beta | Levered Beta limited to 0.8 to 2.0 (practical range for a stable firm) |
1.36 |
| Discount Rate/ Cost of Equity |
= Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 2.31% + (1.361 * 5.96%) |
10.43% |
Discounted Cash Flow Calculation for ASX:NUF using 2 Stage Free Cash Flow to Equity Model
The calculations below outline how an intrinsic value for Nufarm is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.
| Levered FCF (AUD, Millions) | Source |
Present Value Discounted (@ 10.43%) |
|
|---|---|---|---|
| 2019 | 94.00 | Analyst x1 | 85.12 |
| 2020 | 275.50 | Analyst x2 | 225.93 |
| 2021 | 305.50 | Analyst x2 | 226.88 |
| 2022 | 271.00 | Analyst x1 | 182.25 |
| 2023 | 283.00 | Analyst x1 | 172.35 |
| 2024 | 284.12 | Est @ 0.4% | 156.70 |
| 2025 | 286.89 | Est @ 0.97% | 143.28 |
| 2026 | 290.83 | Est @ 1.37% | 131.54 |
| 2027 | 295.64 | Est @ 1.66% | 121.09 |
| 2028 | 301.12 | Est @ 1.85% | 111.69 |
| Present value of next 10 years cash flows | A$1,556.84 | ||
| Calculation | Result | |
|---|---|---|
| Terminal Value |
= FCF2028
× (1 + g) ÷ (Discount Rate – g)
= A$301.12 × (1 + 2.31%) ÷ (10.43% – 2.31%) |
A$3,796.70 |
| Present Value of Terminal Value |
= Terminal Value ÷ (1 + r)10
= A$3,796.70 ÷ (1 + 10.43%)10 |
A$1,408.24 |
| Calculation | Result | |
|---|---|---|
| Total Equity Value |
= Present value of next 10 years cash flows +
Terminal Value
= A$1,556.84 + A$1,408.24 |
A$2,965.08 |
| Equity Value per Share (AUD) |
= Total value / Shares Outstanding
= A$2,965.08 / 379.64 |
A$7.81 |
| Calculation | Result | |
|---|---|---|
| Value per share (AUD) | From above. | A$7.81 |
| Current discount | Discount to share price of
A$4.47
= -1 x (A$4.47 - A$7.81) / A$7.81 |
42.8% |
Learn more about our DCF calculations in Simply Wall St’s analysis model .
Current Discount
Current Discount Checks
- Nufarm's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Nufarm's share price is below the future cash flow value, and at a substantial discount (> 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for
it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing
when they are out of season, or how much your home is worth.The amount the stock market is willing to pay for Nufarm's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are
Nufarm's earnings available for a low price, and how does
this compare to other companies in the same industry?
| Data Point | Source | Value |
|---|---|---|
| Earnings Per Share * | Company Filings (2019-01-31) in AUD | A$-0.15 |
| ASX:NUF Share Price ** | ASX (2019-05-23) in AUD | A$4.47 |
| Australia Chemicals Industry PE Ratio | Median Figure of 6 Publicly-Listed Chemicals Companies | 31.63x |
| Australia Market PE Ratio | Median Figure of 542 Publicly-Listed Companies | 16.13x |
* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.
** Primary Listing of Nufarm.
| Calculation | Outcome | |
|---|---|---|
| PE Ratio | = ASX:NUF Share Price ÷ EPS (both in AUD) = 4.47 ÷ -0.15 |
-29.45x |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Nufarm is loss making, we can't compare its value to the AU Chemicals industry average.
- Nufarm is loss making, we can't compare the value of its earnings to the Australia market.
Price based on expected Growth
Does
Nufarm's expected growth come at a high price?
| Data Point | Source | Value |
|---|---|---|
| PE Ratio | See PE Ratio Section | -29.45x |
| Net Income Annual Growth Rate | See Future Growth Section. Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts |
29.1%per year |
| Global Chemicals Industry PEG Ratio | Median Figure of 177 Publicly-Listed Chemicals Companies | 1.55x |
| Australia Market PEG Ratio | Median Figure of 359 Publicly-Listed Companies | 1.45x |
*Line of best fit is calculated by linear regression .
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to calculate PEG ratio for Nufarm, we can't assess if its growth is good value.
Price based on value of assets
What value do investors place on
Nufarm's
assets?
| Data Point | Source | Value |
|---|---|---|
| Book Value per Share | Company Filings (2019-01-31) in AUD | A$5.23 |
| ASX:NUF Share Price * | ASX (2019-05-23) in AUD | A$4.47 |
| Australia Chemicals Industry PB Ratio | Median Figure of 24 Publicly-Listed Chemicals Companies | 4.63x |
| Australia Market PB Ratio | Median Figure of 1,680 Publicly-Listed Companies | 1.65x |
| Calculation | Outcome | |
|---|---|---|
| PB Ratio | = ASX:NUF Share Price ÷ Book Value per Share (both in AUD) = 4.47 ÷ 5.23 |
0.85x |
* Primary Listing of Nufarm.
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Nufarm is good value based on assets compared to the AU Chemicals industry average.
Value checks
We assess Nufarm's value by looking at:- Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
- Is the PE ratio less than the market average, and/ or less than the Chemicals industry average (and greater than 0)? (2 checks)
- Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
- Is the PB ratio less than the Chemicals industry average (and greater than 0)? (1 check) Nufarm has a total score of 3/6, see the detailed checks below.
Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.
Full details on the Value part of the Simply Wall St company analysis model.
NUF Future Performance
How is Nufarm expected to perform in the next 1 to 3 years based on estimates from 12 analysts?
The future performance of a company is measured in the same way as past
performance, by looking at estimated
growth
and how much profit it is expected to make.Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Earnings growth vs Low Risk Savings
- Nufarm's earnings growth is expected to exceed the low risk savings rate of 2.3%.
Growth vs Market Checks
- Nufarm's earnings growth is expected to exceed the Australia market average.
- Nufarm's revenue growth is expected to exceed the Australia market average.
Annual Growth Rates Comparison
| Data Point | Source | Value (per year) |
|---|---|---|
| ASX:NUF Future Earnings Growth Rate | Line of Best Fit* through Consensus Estimate Earnings of 12 Analysts | 29.1% |
| ASX:NUF Future Revenue Growth Rate | Line of Best Fit* through Consensus Estimate Revenue of 12 Analysts | 4.3% |
| Australia Chemicals Industry Earnings Growth Rate | Market Cap Weighted Average | 18.7% |
| Australia Chemicals Industry Revenue Growth Rate | Market Cap Weighted Average | 5.9% |
| Australia Market Earnings Growth Rate | Market Cap Weighted Average | 7% |
| Australia Market Revenue Growth Rate | Market Cap Weighted Average | 3.2% |
*Line of best fit is calculated by linear regression .
Industry and Market average data is calculated daily.
Learn more about our growth rate calculations in Simply Wall St’s analysis model.
Analysts growth expectations
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
| Date (Data in AUD Millions) | Revenue | Cash Flow | Net Income * | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-07-31 | 4,196 | 262 | 2 | |
| 2022-07-31 | 4,060 | 243 | 2 | |
| 2021-07-31 | 3,942 | 330 | 182 | 11 |
| 2020-07-31 | 3,799 | 322 | 155 | 11 |
| 2019-07-31 | 3,583 | 256 | 97 | 12 |
| Date (Data in AUD Millions) | Revenue | Cash Flow | Net Income * |
|---|---|---|---|
| 2019-01-31 | 3,424 | -281 | -52 |
| 2018-10-31 | 3,366 | -185 | -39 |
| 2018-07-31 | 3,308 | -88 | -26 |
| 2018-04-30 | 3,260 | -41 | 35 |
| 2018-01-31 | 3,211 | 5 | 96 |
| 2017-10-31 | 3,161 | 30 | 99 |
| 2017-07-31 | 3,111 | 55 | 103 |
| 2017-04-30 | 3,037 | 146 | 115 |
| 2017-01-31 | 2,964 | 236 | 127 |
| 2016-10-31 | 2,877 | 187 | 72 |
| 2016-07-31 | 2,791 | 137 | 16 |
| 2016-04-30 | 2,766 | 166 | -33 |
*GAAP earnings excluding extraordinary items.
Past and Future Earnings per Share
| Data Point | Source | Value |
|---|---|---|
| Past Financials | Company Filings (3 months ago) | See Below |
| Future Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
All data from Nufarm Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | EPS * | EPS High Estimate | EPS Low Estimate | Avg. No. Analysts |
|---|---|---|---|---|
| 2023-07-31 | 0.67 | 0.76 | 0.58 | 2.00 |
| 2022-07-31 | 0.62 | 0.70 | 0.54 | 2.00 |
| 2021-07-31 | 0.48 | 0.65 | 0.38 | 7.00 |
| 2020-07-31 | 0.40 | 0.54 | 0.31 | 6.00 |
| 2019-07-31 | 0.26 | 0.34 | 0.22 | 6.00 |
| Date (Data in AUD Millions) | EPS * |
|---|---|
| 2019-01-31 | -0.15 |
| 2018-10-31 | -0.12 |
| 2018-07-31 | -0.08 |
| 2018-04-30 | 0.12 |
| 2018-01-31 | 0.34 |
| 2017-10-31 | 0.36 |
| 2017-07-31 | 0.39 |
| 2017-04-30 | 0.43 |
| 2017-01-31 | 0.48 |
| 2016-10-31 | 0.27 |
| 2016-07-31 | 0.06 |
| 2016-04-30 | -0.13 |
*GAAP earnings excluding extraordinary items.
Future performance checks
We assess Nufarm's future performance by looking at:- Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
- Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Australia market? (1 check)
- Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Australia market? (1 check)
- Is the annual earnings growth rate expected to be above 20%? (1 check)
- Is the annual revenue growth rate expected to be above 20%? (1 check)
- Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Nufarm has a total score of 4/6, see the detailed checks below.
Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.
Full details on the Future part of the Simply Wall St company analysis model.
NUF Past Performance
How has Nufarm performed over the past 5 years?
The past performance of a company can be measured by how much
growth
it has experienced and how much profit it makes relative to the funds and assets
it has available.
Past earnings growth
Past Earnings growth analysis
- Nufarm does not make a profit and their year on year earnings growth rate was negative over the past 5 years.
- Unable to compare Nufarm's 1-year earnings growth to the 5-year average as it is not currently profitable.
- Unable to compare Nufarm's 1-year growth to the Global Chemicals industry average as it is not currently profitable.
Earnings and Revenue History
All data from Nufarm Company Filings, last reported 3 months ago, and in Trailing twelve months (TTM) annual period rather than quarterly.
| Date (Data in AUD Millions) | Revenue | Net Income * | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 2019-01-31 | 3,423.83 | -52.09 | 721.97 | 34.32 |
| 2018-10-31 | 3,365.84 | -39.22 | 694.29 | 36.68 |
| 2018-07-31 | 3,307.85 | -26.35 | 666.62 | 39.05 |
| 2018-04-30 | 3,259.51 | 34.60 | 640.78 | 38.42 |
| 2018-01-31 | 3,211.18 | 95.55 | 614.95 | 37.79 |
| 2017-10-31 | 3,161.15 | 99.36 | 600.18 | 39.05 |
| 2017-07-31 | 3,111.12 | 103.17 | 585.41 | 40.32 |
| 2017-04-30 | 3,037.40 | 115.10 | 570.26 | 40.83 |
| 2017-01-31 | 2,963.68 | 127.02 | 555.12 | 41.35 |
| 2016-10-31 | 2,877.45 | 71.59 | 534.88 | 40.34 |
| 2016-07-31 | 2,791.22 | 16.16 | 514.64 | 39.34 |
| 2016-04-30 | 2,766.13 | -33.30 | 517.11 | 37.05 |
| 2016-01-31 | 2,741.04 | -82.77 | 519.59 | 34.77 |
| 2015-10-31 | 2,739.10 | -25.90 | 514.04 | 33.73 |
| 2015-07-31 | 2,737.16 | 30.96 | 508.49 | 32.68 |
| 2015-04-30 | 2,702.69 | 30.45 | 496.63 | 32.30 |
| 2015-01-31 | 2,668.22 | 29.94 | 484.77 | 31.92 |
| 2014-10-31 | 2,645.46 | 27.64 | 479.59 | 35.47 |
| 2014-07-31 | 2,622.70 | 25.34 | 474.41 | 39.03 |
| 2014-04-30 | 2,551.90 | 51.93 | 460.31 | 44.45 |
| 2014-01-31 | 2,481.09 | 78.51 | 446.22 | 49.86 |
| 2013-10-31 | 2,379.19 | 72.77 | 430.32 | 46.28 |
| 2013-07-31 | 2,277.29 | 67.03 | 414.42 | 42.70 |
| 2013-04-30 | 2,265.28 | 57.54 | 406.45 | 40.23 |
| 2013-01-31 | 2,253.26 | 48.06 | 398.49 | 37.76 |
| 2012-10-31 | 2,217.41 | 53.30 | 391.67 | 37.82 |
| 2012-07-31 | 2,181.55 | 58.55 | 384.85 | 37.87 |
*GAAP earnings excluding extraordinary items.
Performance last year
We want to ensure a company is making the most of what it has available. This is
done by comparing the return (profit) to a company's available
funds,
assets
and
capital.
- It is difficult to establish if Nufarm has efficiently used shareholders’ funds last year (Return on Equity greater than 20%) as it is loss-making.
- Nufarm used its assets less efficiently than the AU Chemicals industry average last year based on Return on Assets.
- It is difficult to establish if Nufarm improved its use of capital last year versus 3 years ago (Return on Capital Employed) as it is currently loss-making.
Past performance checks
We assess Nufarm's performance over the past 5 years by checking for:- Has earnings increased in past 5 years? (1 check)
- Has the earnings growth in the last year exceeded that of the Chemicals industry? (1 check)
- Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
- Is the Return on Equity (ROE) higher than 20%? (1 check)
- Is the Return on Assets (ROA) above industry average? (1 check)
- Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
Nufarm has a total score of 0/6, see the detailed checks below.
Note: We use GAAP Net Income excluding extraordinary items in all our calculations.
Full details on the Past part of the Simply Wall St company analysis model.
NUF Health
How is Nufarm's financial health and their level of debt?
A company's financial position is much like your own financial position,
it includes everything you own
(assets)
and owe
(liabilities).The boxes below represent the relative size of what makes up Nufarm's finances.
The net worth of a company is the difference between its assets and liabilities.
- Nufarm is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Nufarm's cash and other short term assets cover its long term commitments.
Balance sheet
Assets
Liabilities and shares
- High level of physical assets or inventory.
- Debt is covered by short term assets, assets are 1.8x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t
bad,
however if the debt is too high, or the company can’t afford to pay the interest
on its debts this may have impacts in the future.The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.
If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
All data from Nufarm Company Filings, last reported 3 months ago.
| Date (Data in AUD Millions) | Total Equity | Total Debt | Cash & Short Term Investments |
|---|---|---|---|
| 2019-01-31 | 2,232.64 | 1,917.27 | 340.14 |
| 2018-10-31 | 2,232.64 | 1,917.27 | 340.14 |
| 2018-07-31 | 1,971.62 | 1,675.77 | 301.70 |
| 2018-04-30 | 1,971.62 | 1,675.77 | 301.70 |
| 2018-01-31 | 2,021.58 | 936.24 | 392.43 |
| 2017-10-31 | 2,021.58 | 936.24 | 392.43 |
| 2017-07-31 | 1,602.92 | 915.44 | 235.15 |
| 2017-04-30 | 1,602.92 | 915.44 | 235.15 |
| 2017-01-31 | 1,534.43 | 1,109.78 | 253.39 |
| 2016-10-31 | 1,534.43 | 1,109.78 | 253.39 |
| 2016-07-31 | 1,550.23 | 906.88 | 320.01 |
| 2016-04-30 | 1,550.23 | 906.88 | 320.01 |
| 2016-01-31 | 1,464.24 | 1,210.73 | 283.70 |
| 2015-10-31 | 1,464.24 | 1,210.73 | 283.70 |
| 2015-07-31 | 1,636.80 | 938.14 | 391.42 |
| 2015-04-30 | 1,636.80 | 938.14 | 391.42 |
| 2015-01-31 | 1,669.16 | 1,182.18 | 292.57 |
| 2014-10-31 | 1,669.16 | 1,182.18 | 292.57 |
| 2014-07-31 | 1,608.70 | 776.10 | 241.64 |
| 2014-04-30 | 1,608.70 | 776.10 | 241.64 |
| 2014-01-31 | 1,650.24 | 1,239.60 | 217.05 |
| 2013-10-31 | 1,650.24 | 1,239.60 | 217.05 |
| 2013-07-31 | 1,664.75 | 920.40 | 264.97 |
| 2013-04-30 | 1,664.75 | 920.40 | 264.97 |
| 2013-01-31 | 1,500.89 | 959.11 | 216.53 |
| 2012-10-31 | 1,500.89 | 959.11 | 216.53 |
| 2012-07-31 | 1,476.80 | 659.12 | 191.32 |
- Nufarm's level of debt (85.9%) compared to net worth is high (greater than 40%).
- The level of debt compared to net worth has increased over the past 5 years (74.8% vs 85.9% today).
- Operating cash flow is negative therefore debt is not well covered.
- Nufarm is making a loss, therefore interest payments are not well covered by earnings.
Financial health checks
We assess Nufarm's financial health by checking for:- Are short term assets greater than short term liabilities? (1 check)
- Are short term assets greater than long term liabilities? (1 check)
- Has the debt to equity ratio increased in the past 5 years? (1 check)
- Is the debt to equity ratio over 40%? (1 check)
- Is the debt covered by operating cash flow? (1 check)
- Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check) Nufarm has a total score of 2/6, see the detailed checks below.
- Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
- Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
Full details on the Health part of the Simply Wall St company analysis model.
NUF Dividends
What is Nufarm's current dividend yield, its reliability and sustainability?
Dividends are regular cash payments to you from the company, similar to a
bank paying you interest on a savings account.
Annual Dividend Income
If you bought
A$2,000 of
Nufarm
shares you are expected to receive
A$0
in your first year as a dividend.
Dividend Amount
- Unable to evaluate Nufarm's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Nufarm's dividend against the top 25% market benchmark as the company has not reported any payouts.
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not
wildly increasing/decreasing each year. This graph shows you the historical rate
to count toward your assessment of the stock.We also check to see if the dividend has increased in the past 10 years.
| Data Point | Source | Value |
|---|---|---|
| Past Annualized Dividend Yield | S&P Global Market Data | See Below |
| Past Dividends per Share | Company Filings/ Annualized Dividend Payments | See Below |
| Future Dividends per Share Estimates | Average of up to 12 Analyst Estimates (S&P Global) | See Below |
| Global Chemicals Industry Average Dividend Yield | Market Cap Weighted Average of 332 Stocks | 2.6% |
| Australia Market Average Dividend Yield | Market Cap Weighted Average of 414 Stocks | 4.1% |
| Australia Minimum Threshold Dividend Yield | 10th Percentile | 1.6% |
| Australia Bottom 25% Dividend Yield | 25th Percentile | 2.6% |
| Australia Top 25% Dividend Yield | 75th Percentile | 5.7% |
Industry and Market average data is calculated daily.
Note all dividend per share amounts are annualized and not quarterly or other period.
| Date (Data in A$) | Dividend per Share (annual) | Avg. No. Analysts |
|---|---|---|
| 2023-07-31 | 0.23 | 2.00 |
| 2022-07-31 | 0.22 | 2.00 |
| 2021-07-31 | 0.15 | 12.00 |
| 2020-07-31 | 0.12 | 11.00 |
| 2019-07-31 | 0.07 | 5.00 |
| Date (Data in A$) | Dividend per share (annual) | Avg. Yield (%) |
|---|---|---|
| 2019-03-19 | 0.000 | 0.000 |
| 2018-10-01 | 0.130 | 2.240 |
| 2018-03-20 | 0.130 | 1.604 |
| 2017-09-25 | 0.130 | 1.534 |
| 2017-03-21 | 0.120 | 1.276 |
| 2016-09-20 | 0.110 | 1.227 |
| 2015-09-22 | 0.100 | 1.303 |
| 2015-03-24 | 0.090 | 1.243 |
| 2014-09-22 | 0.080 | 1.519 |
| 2013-09-24 | 0.100 | 2.296 |
| 2013-03-28 | 0.060 | 1.336 |
| 2012-09-24 | 0.060 | 1.063 |
| 2012-03-27 | 0.060 | 1.164 |
| 2011-03-28 | 0.000 | 0.000 |
| 2010-09-28 | 0.000 | 0.000 |
| 2010-03-29 | 0.000 | 0.000 |
| 2009-09-28 | 0.270 | 2.570 |
Learn more about our ratios and growth rates in Simply Wall St’s analysis model >
- Unable to perform a dividend volatility check as Nufarm has not reported any payouts.
- Unable to verify if Nufarm's dividend has been increasing as the company has not reported any payouts.
Income/ dividend checks
We assess Nufarm's dividend by checking for:- Firstly is the company paying a notable dividend (greater than 1.6%) - if not then the rest of the checks are ignored.
- Is current dividend yield above the bottom 25% of dividend payers? (1 check)
- Is current dividend yield above the top 25% of dividend payers? (1 check)
- Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
- If they have paid a dividend for 10 years has it increased in this time? (1 check)
- How sustainable is the dividend, can Nufarm afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks) Nufarm has a total score of 1/6, see the detailed checks below.
Full details on the Dividends part of the Simply Wall St company analysis model.
NUF Management
CEO
| COMPENSATION | A$1,851,114 |
| AGE | 59 |
| TENURE AS CEO | 4 years |
CEO Bio
Mr. Gregory Allan Hunt, also known as Greg, Grad. Dip., Mgmnt, AMP Harvard, AICD, REBA, has been the Chief Executive Officer and Managing Director of Nufarm Limited since May 05, 2015. Mr. Hunt serves as Managing Director and Chief Executive Officer of Nufarm Australia Limited. He served as an Acting Chief Executive Officer of Nufarm Limited from February 4, 2015 to May 04, 2015 and served as its Chief Operating Officer. Mr. Hunt served as Group Executive of Commercial Operations at Nufarm Limited. Mr. Hunt served as Group Executive for Regional Crop Protection Businesses at Nufarm Limited since February 2014. Mr. Hunt served as Group Executive of Global Marketing and Business Development at Nufarm Limited. Mr. Hunt served as Group Executive Global Marketing and Business Development of Nufarm Limited and served as its Group General Manager of Global Marketing and Business Development since February 6, 2012. He has worked in the agribusiness industry for over 30 years and served as Chief Executive Officer of Elders Ltd. Mr. Hunt has considerable executive and agribusiness experience. He served as Managing Director of Elders Australia Ltd. at Elders Ltd. (also known as Futuris Corp. Ltd) from 2001 to July 13, 2007, where Mr. Hunt served a number of management positions focused on both the Australian and international operations and led its operations across a broad range of activity, including rural merchandising and product distribution. He worked with a number of organisations in business development and agribusiness related investment advisory roles and has assisted companies including Tandou Ltd, Plum Grove Pty Ltd and Biocentral laboratories Ltd. Mr. Hunt served as Managing Director of BWK Ag (Germany), Australian Agricultural Company Ltd., Killara Feedlot Pty Ltd., Webster Ltd., HiFert Pty Ltd., Walnuts Australia Pty Ltd., Elders Indonesia and Elders Insurance Ltd. Mr. Hunt serves as the Chairman of Elementree Pty Ltd., Biocentral Laboratories, Kirribilli Pastoral and Plumgrove Pty Ltd. He has been an Executive Director of Nufarm Limited since May 05, 2015. He serves as Director of Elders Insurance Limited, Elders Australia Limited, Commissioner PT Elders Indonesia. He served as Director of Costa Group Holdings Limited from October 07, 2011 to June 2015. Mr. Hunt served as a Non-executive Independent Director of Plum Grove Pty Ltd. Mr. Hunt served as Director of Elders Rural Bank Limited from July 2002 to July 14, 2006. He served as Independent Non-Executive Director of Tandou Ltd. from November 21, 2007 to February 29, 2012. Mr. Hunt served as a Non Executive Director of Webster Ltd. from January 23, 2004 to October 24, 2007. He served as Director of Tassal Group Ltd. until August 2005. Mr. Hunt attended Harvard University (AMP) and has Graduate Management Qualifications from Australian Institute of Company Directors.
CEO Compensation
- Greg's compensation has been consistent with company performance over the past year, both up more than 20%.
- Greg's remuneration is about average for companies of similar size in Australia.
Management Team Tenure
Average tenure of the Nufarm management team in years:
- The tenure for the Nufarm management team is about average.
Management Team
Greg Hunt
MD, CEO & Executive Director
A$2M
59
4 yrs
Paul Binfield
Chief Financial Officer
A$1M
53
7.5 yrs
Rod Heath
Group Executive of Corporate Services & Company Secretary
19.3 yrs
Mark Keating
General Manager of Investor Relations
3.7 yrs
John Holding
Group Executive of People & Performance
1.3 yrs
Board of Directors Tenure
Average tenure and age of the Nufarm board of directors in years:
- The tenure for the Nufarm board of directors is about average.
Board of Directors
Donald McGauchie
Chairman
A$378K
68
8.8 yrs
Greg Hunt
MD, CEO & Executive Director
A$2M
59
4 yrs
Gordon Davis
Non-Executive Independent Director
A$202K
62
8 yrs
Peter Margin
Non-Executive Independent Director
A$198K
58
7.6 yrs
Frank Ford
Non-Executive Independent Director
A$191K
72
6.6 yrs
Anne Brennan
Non-Executive Independent Director
A$183K
58
8.3 yrs
Toshikazu Takasaki
Non-Executive Director
A$164K
71
6.4 yrs
Marie McDonald
Non-Executive Director
A$184K
62
2.2 yrs
Who owns this company?
Recent Insider Trading
- More shares have been bought than sold by Nufarm insiders in the past 3 months.
Recent Insider Transactions
| Announced | Type | Name | Entity | Role | Start | End | Shares | Max Price (A$) | Value (A$) | |
|---|---|---|---|---|---|---|---|---|---|---|
| 03. May 19 | Sell | Hua Zhang | Individual | 17. Oct 18 | 22. Oct 18 | -1,773,822 | A$5.96 | A$-10,376,199 | ||
| 23. Apr 19 | Sell | Ellerston Capital Limited | Company | 18. Dec 18 | 20. Mar 19 | -2,992,800 | A$6.18 | A$-18,499,095 | ||
| 23. Apr 19 | Buy | Ellerston Capital Limited | Company | 29. Nov 18 | 18. Apr 19 | 7,851,042 | A$5.45 | A$42,806,643 | ||
| 26. Mar 19 | Sell | Macquarie Investment Management Australia Limited | Company | 21. Mar 19 | 21. Mar 19 | -216,871 | A$4.50 | A$-975,919 | ||
| 26. Mar 19 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 21. Mar 19 | 21. Mar 19 | -144,934 | A$4.45 | A$0 | ||
| 26. Mar 19 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 21. Mar 19 | 21. Mar 19 | 11,855 | A$4.50 | A$26,258 | ||
| 26. Mar 19 | Sell | Macquarie Capital Investment Management LLC | Company | 21. Mar 19 | 21. Mar 19 | -104,602 | A$4.50 | A$0 | ||
| 26. Mar 19 | Sell | Macquarie Investment Management Limited | Company | 21. Mar 19 | 21. Mar 19 | -4,965 | A$4.47 | A$0 | ||
| 26. Mar 19 | Buy | Macquarie Investment Management Limited | Company | 21. Mar 19 | 21. Mar 19 | 20,893 | A$4.47 | A$0 | ||
| 28. Mar 19 | Buy | Nikko Asset Management Co., Ltd. | Company | 22. Mar 19 | 25. Mar 19 | 5,076,069 | A$4.67 | A$23,686,470 | ||
| 26. Mar 19 | Buy | Nikko Asset Management Co., Ltd. | Company | 21. Nov 18 | 21. Mar 19 | 14,092,464 | A$6.26 | A$77,574,782 | ||
| 25. Mar 19 | Sell | Macquarie Capital Investment Management LLC | Company | 15. Mar 19 | 15. Mar 19 | -58,437 | A$5.36 | A$-313,222 | ||
| 25. Mar 19 | Buy | Macquarie Capital Investment Management LLC | Company | 18. Dec 18 | 09. Jan 19 | 80,055 | A$6.11 | A$0 | ||
| 25. Mar 19 | Sell | Macquarie Investment Management Australia Limited | Company | 20. Dec 18 | 19. Mar 19 | -136,747 | A$6.28 | A$0 | ||
| 25. Mar 19 | Buy | Macquarie Investment Management Australia Limited | Company | 06. Dec 18 | 15. Mar 19 | 636,955 | A$6.46 | A$0 | ||
| 25. Mar 19 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 06. Dec 18 | 20. Mar 19 | -226,891 | A$6.54 | A$0 | ||
| 25. Mar 19 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 06. Dec 18 | 20. Mar 19 | 226,891 | A$6.54 | A$0 | ||
| 25. Mar 19 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 03. Dec 18 | 20. Mar 19 | -2,126,983 | A$6.56 | A$0 | ||
| 25. Mar 19 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 03. Dec 18 | 20. Mar 19 | 2,648,958 | A$6.58 | A$0 | ||
| 25. Mar 19 | Sell | Macquarie Investment Management Limited | Company | 07. Dec 18 | 20. Mar 19 | -25,255 | A$6.50 | A$0 | ||
| 25. Mar 19 | Buy | Macquarie Investment Management Limited | Company | 03. Dec 18 | 20. Mar 19 | 2,158,736 | A$6.55 | A$0 | ||
| 25. Mar 19 | Buy | Fransis Ford | Individual | 21. Mar 19 | 22. Mar 19 | 18,095 | A$4.62 | A$80,877 | ||
| 22. Mar 19 | Buy | Gordon Davis | Individual | 21. Mar 19 | 21. Mar 19 | 15,000 | A$4.47 | A$67,050 | ||
| 22. Mar 19 | Buy | Gregory Hunt | Individual | 21. Mar 19 | 21. Mar 19 | 23,500 | A$4.27 | A$100,345 | ||
| 20. Feb 19 | Sell | Perpetual Limited | Company | 08. Feb 19 | 18. Feb 19 | -2,342,067 | A$5.61 | A$-13,145,698 | ||
| 11. Feb 19 | Sell | Perpetual Limited | Company | 07. Jan 19 | 07. Feb 19 | -4,154,140 | A$6.28 | A$-26,075,057 | ||
| 10. Jan 19 | Sell | United Super Pty Ltd | Company | 07. Jan 19 | 08. Jan 19 | -155,819 | A$6.11 | A$-941,331 | ||
| 10. Jan 19 | Buy | United Super Pty Ltd | Company | 21. Dec 18 | 04. Jan 19 | 42,423 | A$5.77 | A$241,925 | ||
| 26. Dec 18 | Buy | United Super Pty Ltd | Company | 20. Dec 18 | 20. Dec 18 | 65,789 | A$6.01 | A$395,094 | ||
| 21. Dec 18 | Sell | Perpetual Limited | Company | 20. Nov 18 | 19. Dec 18 | -6,423,507 | A$6.09 | A$-39,087,310 | ||
| 21. Dec 18 | Buy | Perpetual Limited | Company | 26. Oct 18 | 10. Dec 18 | 2,991,389 | A$5.71 | A$17,087,369 | ||
| 21. Dec 18 | Sell | United Super Pty Ltd | Company | 19. Dec 18 | 19. Dec 18 | -361,210 | A$6.07 | A$-2,191,937 | ||
| 21. Dec 18 | Buy | United Super Pty Ltd | Company | 17. Dec 18 | 19. Dec 18 | 310,973 | A$6.08 | A$1,887,198 | ||
| 17. Dec 18 | Sell | United Super Pty Ltd | Company | 03. Dec 18 | 06. Dec 18 | -320,016 | A$6.47 | A$-1,993,449 | ||
| 17. Dec 18 | Buy | United Super Pty Ltd | Company | 07. Dec 18 | 13. Dec 18 | 521,805 | A$6.02 | A$3,064,183 | ||
| 03. Dec 18 | Sell | Macquarie Investment Management Australia Limited | Company | 09. Oct 18 | 10. Oct 18 | -355,590 | A$6.00 | A$0 | ||
| 03. Dec 18 | Buy | Macquarie Investment Management Australia Limited | Company | 01. Oct 18 | 22. Nov 18 | 1,162,446 | A$5.84 | A$6,787,521 | ||
| 03. Dec 18 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 12. Oct 18 | 28. Nov 18 | -14,850 | A$5.91 | A$0 | ||
| 03. Dec 18 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 12. Oct 18 | 28. Nov 18 | 14,850 | A$5.91 | A$0 | ||
| 03. Dec 18 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 07. Aug 18 | 28. Nov 18 | -764,133 | A$7.56 | A$0 | ||
| 03. Dec 18 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 06. Aug 18 | 28. Nov 18 | 956,430 | A$7.56 | A$0 | ||
| 03. Dec 18 | Sell | Macquarie Investment Management Limited | Company | 31. Jul 18 | 27. Nov 18 | -9,411 | A$7.11 | A$0 | ||
| 03. Dec 18 | Buy | Macquarie Investment Management Limited | Company | 08. Aug 18 | 16. Nov 18 | 66,765 | A$7.47 | A$0 | ||
| 05. Dec 18 | Buy | Macquarie Investment Management Australia Limited | Company | 29. Nov 18 | 29. Nov 18 | 3,272 | A$6.13 | A$20,057 | ||
| 05. Dec 18 | Sell | Macquarie Group, Ltd., Banking & Securities Investments | Company | 29. Nov 18 | 30. Nov 18 | -80,243 | A$6.15 | A$0 | ||
| 05. Dec 18 | Buy | Macquarie Group, Ltd., Banking & Securities Investments | Company | 29. Nov 18 | 30. Nov 18 | 16,593 | A$6.08 | A$0 | ||
| 04. Dec 18 | Sell | United Super Pty Ltd | Company | 16. Nov 18 | 30. Nov 18 | -560,808 | A$6.15 | A$-3,373,849 | ||
| 04. Dec 18 | Buy | United Super Pty Ltd | Company | 15. Nov 18 | 22. Nov 18 | 337,837 | A$6.09 | A$2,022,108 | ||
| 23. Nov 18 | Sell | Ellerston Capital Limited | Company | 16. Oct 18 | 14. Nov 18 | -987,339 | A$5.88 | A$-5,803,292 | ||
| 23. Nov 18 | Buy | Ellerston Capital Limited | Company | 13. Sep 18 | 22. Nov 18 | 13,082,569 | A$5.87 | A$76,794,491 | ||
| 06. Nov 18 | Sell | Firetrail Investments Pty Ltd | Company | 10. Oct 18 | 05. Nov 18 | -3,999,024 | A$5.81 | A$-23,227,760 | ||
| 06. Nov 18 | Buy | Firetrail Investments Pty Ltd | Company | 10. Oct 18 | 10. Oct 18 | 1,849,369 | A$5.88 | A$10,867,037 | ||
| 30. Oct 18 | Buy | Peter Margin | Individual | 26. Oct 18 | 26. Oct 18 | 475 | A$5.85 | A$2,779 | ||
| 30. Oct 18 | Buy | Marie McDonald | Individual | 26. Oct 18 | 26. Oct 18 | 1,355 | A$5.85 | A$7,927 | ||
| 30. Oct 18 | Buy | M.A. Goodfellow | Individual | 26. Oct 18 | 26. Oct 18 | 2,510 | A$5.85 | A$14,683 | ||
| 30. Oct 18 | Buy | Sulkem Company Limited | Company | 26. Oct 18 | 26. Oct 18 | 25,376 | A$5.85 | A$148,450 | ||
| 30. Oct 18 | Buy | Goodfellow Foundation & Ppl Accounts Ltd., Endowment Arm | Company | 26. Oct 18 | 26. Oct 18 | 6,534 | A$5.85 | A$38,224 | ||
| 30. Oct 18 | Buy | Fransis Ford | Individual | 26. Oct 18 | 26. Oct 18 | 3,860 | A$5.85 | A$22,581 | ||
| 30. Oct 18 | Buy | Gordon Davis | Individual | 26. Oct 18 | 26. Oct 18 | 7,720 | A$5.85 | A$45,162 | ||
| 30. Oct 18 | Buy | William Goodfellow | Individual | 26. Oct 18 | 26. Oct 18 | 109,181 | A$5.85 | A$638,709 | ||
| 30. Oct 18 | Buy | Anne Brennan | Individual | 26. Oct 18 | 26. Oct 18 | 1,932 | A$5.85 | A$11,302 | ||
| 30. Oct 18 | Buy | Gregory Hunt | Individual | 26. Oct 18 | 26. Oct 18 | 47,981 | A$5.85 | A$280,689 | ||
| 30. Oct 18 | Buy | Gregory Hunt | Individual | 30. Oct 18 | 30. Oct 18 | 33,509 | A$5.37 | A$179,943 | ||
| 30. Oct 18 | Buy | Donald McGauchie | Individual | 26. Oct 18 | 26. Oct 18 | 10,468 | A$5.85 | A$61,238 | ||
| 26. Oct 18 | Buy | Perpetual Limited | Company | 01. Oct 18 | 24. Oct 18 | 6,833,661 | A$5.87 | A$40,127,419 | ||
| 11. Oct 18 | Sell | Hua Zhang | Individual | 24. Feb 18 | 11. Oct 18 | -3,348,828 | A$6.78 | A$-22,715,622 | ||
| 10. Oct 18 | Buy | Marie McDonald | Individual | 09. Oct 18 | 10. Oct 18 | 12,388 | A$6.19 | A$74,874 | ||
| 08. Oct 18 | Buy | Fransis Ford | Individual | 05. Oct 18 | 05. Oct 18 | 5,000 | A$6.07 | A$30,350 | ||
| 20. Sep 18 | Buy | Firetrail Investments Pty Ltd | Company | 14. Mar 18 | 18. Sep 18 | 18,166,896 | A$8.93 | A$134,033,024 | ||
| 20. Sep 18 | Sell | Perpetual Limited | Company | 21. Aug 18 | 18. Sep 18 | -3,969,722 | A$6.98 | A$-27,689,646 | ||
| 20. Sep 18 | Buy | Perpetual Limited | Company | 21. Aug 18 | 21. Aug 18 | 300,000 | A$6.70 | A$2,009,040 | ||
| 10. Sep 18 | Buy | Ellerston Capital Limited | Company | 19. Apr 18 | 07. Sep 18 | 8,960,506 | A$8.04 | A$72,010,262 | ||
| 15. Aug 18 | Buy | Perpetual Limited | Company | 23. Jul 18 | 13. Aug 18 | 5,536,981 | A$6.98 | A$38,675,453 | ||
| 24. Jul 18 | Sell | Perpetual Limited | Company | 16. Jul 18 | 16. Jul 18 | -495,681 | A$8.25 | A$-4,089,368 | ||
| 24. Jul 18 | Buy | Perpetual Limited | Company | 12. Jun 18 | 20. Jul 18 | 3,790,712 | A$8.55 | A$32,422,347 | ||
| 13. Jun 18 | Sell | Perpetual Limited | Company | 22. Mar 18 | 24. May 18 | -2,171,475 | A$8.73 | A$-18,966,795 | ||
| 13. Jun 18 | Buy | Perpetual Limited | Company | 22. Mar 18 | 08. Jun 18 | 4,561,094 | A$8.81 | A$40,176,433 | ||
Management checks
We assess Nufarm's management by checking for:- Is the CEO's compensation unreasonable compared to market cap? (1 check)
- Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
- Is the average tenure of the management team less than 2 years? (1 check)
- Is the average tenure of the board of directors team less than 3 years? (1 check) Nufarm has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.
Note: We use the top 6 management executives and board members in our calculations.
Note 2: Insider trading include any internal stakeholders and these transactions .
Full details on the Management part of the Simply Wall St company analysis model.
NUF News
Simply Wall St News
What Kind Of Shareholders Own Nufarm Limited (ASX:NUF)?
Taking a look at our data on the ownership groups (below), it's seems that institutional investors have bought into the company. … View our latest analysis for Nufarm ASX:NUF Ownership Summary, May 13th 2019 What Does The Institutional Ownership Tell Us About Nufarm? … We can see that Nufarm does have institutional investors; and they hold 60% of the stock.
Simply Wall St - – Full articleIs There An Opportunity With Nufarm Limited's (ASX:NUF) 31% Undervaluation?
I will use the Discounted Cash Flow (DCF) model. … We generally believe that a company's value is the present value of all of the cash it will generate in the future. … If you want to learn more about discounted cash flow, the rationale behind this calculation can be read in detail in the Simply Wall St analysis model.
Simply Wall St - – Full articleIs Nufarm Limited's (ASX:NUF) CEO Paid Enough Relative To Peers?
This analysis aims first to contrast CEO compensation with other companies that have similar market capitalization. … How Does Greg Hunt's Compensation Compare With Similar Sized Companies. … At the time of writing our data says that Nufarm Limited has a market cap of AU$1.9b, and is paying total annual CEO compensation of AU$1.9m.
Simply Wall St - – Full articleWhat Type Of Shareholder Owns Nufarm Limited's (ASX:NUF)?
If you want to know who really controls Nufarm Limited (ASX:NUF), then you'll have to look at the makeup of its share registry. … Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have institutions as shareholders. … Our analysis of the ownership of the company, below, shows that.
Simply Wall St - – Full articleWhat does Nufarm Limited's (ASX:NUF) Balance Sheet Tell Us About Its Future?
Investors are always looking for growth in small-cap stocks like Nufarm Limited (ASX:NUF), with a market cap of AU$2.3b. … However, an important fact which most ignore is: how financially healthy is the business? … the current state of its operations and pathway to profitability.
Simply Wall St - – Full articleDoes Nufarm Limited (ASX:NUF) Have A High Beta?
Modern finance theory considers volatility to be a measure of risk, and there are two main types of price volatility. … Some stocks mimic the volatility of the market quite closely, while others demonstrate muted, exagerrated or uncorrelated price movements. … Beta can be a useful tool to understand how much a stock is influenced by market risk (volatility).
Simply Wall St - – Full articleIs Nufarm Limited's (ASX:NUF) CEO Paid At A Competitive Rate?
How Does Greg Hunt's Compensation Compare With Similar Sized Companies. … Our data indicates that Nufarm Limited is worth AU$2.2b, and total annual CEO compensation is AU$2m. … So Greg Hunt receives a similar amount to the median CEO pay, amongst the companies we looked at.
Simply Wall St - – Full articleRead This Before Buying Nufarm Limited (ASX:NUF) For Its Dividend
A sizeable part of portfolio returns can be produced by dividend stocks due to their contribution to compounding returns in the long run. … Historically, Nufarm Limited (ASX:NUF) has paid dividends to shareholders, and these days it yields 1.9%. … 5 checks you should use to assess a dividend stock
Simply Wall St - – Full articleHow Does Nufarm Limited (ASX:NUF)’s Prospect Stack Up To Its Basic Material Peers?
Nufarm Limited (ASX:NUF), a AU$2.42b. … In addition to cyclicality, chemicals companies face the issue of environmental concerns … This is a key risk that investors have to keep in mind when looking at stocks such as Nufarm due to the risky nature of its activities, which may impact future cash flows
Simply Wall St - – Full articleWhat Investors Should Know About Nufarm Limited's (ASX:NUF) Financial Strength
While small-cap stocks, such as Nufarm Limited (ASX:NUF) with its market cap of AU$2.34b, are popular for their explosive growth, investors should also be aware of their balance sheet to judge whether the company can survive a downturn. … Assessing first and foremost the financial health is. … Here are a few basic checks that are good enough to have a broad overview of the company’s financial strength.
Simply Wall St - – Full articleNUF Company Info
Description
Nufarm Limited, together with its subsidiaries, manufactures and sells crop protection products in Australia, New Zealand, Asia, Europe, North America, and Latin America. It operates through two segments, Crop Protection and Seed Technologies. The company offers herbicides, insecticides, and fungicides to protect crops from damage caused by weeds, pests, and diseases. It also provides seeds and seed treatment products; and engages in croplands equipment business. The company is headquartered in Laverton North, Australia.
Details
| Name: | Nufarm Limited |
| NUF | |
| Exchange: | ASX |
| Founded: | |
| A$1,750,137,329 | |
| 379,639,334 | |
| Website: | http://www.nufarm.com |
| Address: |
Nufarm Limited 103-105 Pipe Road, Laverton North, Victoria, 3026, Australia |
Listings
| Exchange Symbol | Ticker Symbol | Security | Exchange | Country | Currency | Listed on | |
|---|---|---|---|---|---|---|---|
| ASX | NUF | Ordinary Shares | Australian Securities Exchange | AU | AUD | 02. Jan 1992 | |
| OTCPK | NUFM.F | Ordinary Shares | Pink Sheets LLC | US | USD | 02. Jan 1992 | |
| DB | NUF | Ordinary Shares | Deutsche Boerse AG | DE | EUR | 02. Jan 1992 | |
| CHIA | NUF | Ordinary Shares | Chi-X Australia | AU | AUD | 02. Jan 1992 | |
| OTCPK | NFRM.Y | SPONSORED ADR | Pink Sheets LLC | US | USD | 15. Jan 2016 |
Number of employees
Current staff
Industry
| Fertilizers and Agricultural Chemicals | |
| Materials |
Company Analysis and Financial Data Status
| Area | Date (UTC time) |
|---|---|
| Company Analysis updated: | 2019/05/23 10:31 |
| End of day share price update: | 2019/05/23 00:00 |
| Last estimates confirmation: | 2019/05/01 |
| Last earnings filing: | 2019/03/19 |
| Last earnings reported: | 2019/01/31 |
| Last annual earnings reported: | 2018/07/31 |
All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
